← Eichor
Condition: Chronic Kidney Disease In Type 2 Diabetes Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Chronic Kidney Disease In Type 2 Diabetes

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Mechanistic Study on the Effect of HTD1801 Versus Placebo on Kidney Function in Patients With Type 2 Diabetes and Chro
Phase 2 · 1 location(s) · Institute of Medicinal Biotechnology, Chinese Academy of Med · NCT07496177A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Hea
Phase 4 · 12 location(s) · Herlev and Gentofte Hospital · NCT06642272Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa
Phase N/A · 1 location(s) · Swiss Tropical & Public Health Institute · NCT05881447OCTA in Cardiovascular Disease and Healthy Controls
NA · 1 location(s) · University of Erlangen-Nürnberg Medical School · NCT07359664Closed-Loop Impact on Chronic Kidney Disease in Type 2 Diabetes
NA · 2 location(s) · Heba Al-Alwan · NCT06925217A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Livi
Phase 2 · 147 location(s) · Novo Nordisk A/S · NCT06717698Mixed Methods Study of Health-Related Social Needs in African American Adults With Chronic Kidney Disease and Type 2 Dia
Phase N/A · 1 location(s) · Medical College of Wisconsin · NCT05692388iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
Phase N/A · 76 location(s) · AstraZeneca · NCT03549754Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
NA · 7 location(s) · Duke University · NCT06906627Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.
Phase 4 · 1 location(s) · University of Aarhus · NCT07026539A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants a
Phase 1 · 5 location(s) · AstraZeneca · NCT07024823Improving Kidney Care in Type 2 Diabetes: A Study of Pharmacist Prescribing Versus Usual Care
NA · 1 location(s) · Nova Scotia Health Authority · NCT07169422Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease
EARLY_Phase 1 · 1 location(s) · Brigham and Women's Hospital · NCT06190158An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chroni
Phase N/A · 1 location(s) · Bayer · NCT07554469Real World Evidence Clinical Utility Study of KidneyIntelX
Phase N/A · 1 location(s) · Renalytix AI, Inc. · NCT04802395Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidn
Phase 2 · 57 location(s) · Regeneron Pharmaceuticals · NCT07271186Improving Coronary Vascular Health in Women
Phase 2 · 1 location(s) · Massachusetts General Hospital · NCT06843902Evaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney Disease
Phase N/A · 1 location(s) · Second Affiliated Hospital of Soochow University · NCT06838416Nanshan Elderly Cohort Study
Phase N/A · 2 location(s) · Sun Yat-sen University · NCT03569735Cardiovascular Risk in Children With Chronic Conditions Study
Phase N/A · 3 location(s) · Semmelweis University · NCT07086989An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic
Phase N/A · 1 location(s) · Bayer · NCT07232537Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinic
Phase N/A · 1 location(s) · Clindove Research LLC · NCT07106879Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
Phase N/A · 1 location(s) · Cardenal Herrera University · NCT07309094A Study of ONO-3310 in Healthy Adult Male Subjects and Chronic Kidney Disease Patients With Type 2 Diabetes Mellitus
Phase 1 · 1 location(s) · Ono Pharmaceutical Co., Ltd. · NCT07619157Effects and Safety of Diabetic GUideline Algorithm Implementation Performed by Primary Care Physicians in the Community
NA · 13 location(s) · Shanghai Zhongshan Hospital · NCT05349955Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis
Phase 4 · 2 location(s) · Unity Health Toronto · NCT07017270Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Phase 3 · 95 location(s) · Prokidney · NCT05099770Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD
Phase N/A · 1 location(s) · University of Alberta · NCT07187830A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Dia
Phase 3 · 169 location(s) · AstraZeneca · NCT07662135Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors
Phase N/A · 13 location(s) · Herlev Hospital · NCT04916132
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.